ArticleCardiovascular intervention and therapeutics2026
Geometric coronary constraints and anatomical feasibility of redo TAVR in Asian patients with Evolut valves: A CT-based simulation study.
Article in Cardiovascular intervention and therapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Redo transcatheter aortic valve replacement (TAVR) when implanting a second transcatheter valve within a tall-frame self-expanding valve can be challenging because of unfavorable coronary-related anatomy. However, computed tomography (CT)-based data in Asian patients with smaller aortic root dimensions remain limited.This study aimed to evaluate the CT-based geometric coronary constraints by simulating implantation of a balloon-expandable SAPIEN 3 (S3) within a previously implanted self-expanding Evolut valve in Asian patients. Consecutive patients who underwent TAVR using Evolut at a single center between May 2021 and May 2023 and had post-procedural CT were analyzed. Virtual S3-in-Evolut implantation was simulated at three depths (node 4: low; node 5: intermediate; node 6: high). Geometric coronary constraint was assessed based on the relationship between the neo-skirt plane and coronary ostia and the valve-to-aorta distance. Among 113 patients, the distribution of geometric coronary constraint differed by simulated S3 implantation depth. With high S3 implantation (node 6), severe, intermediate, and low constraint were observed in 63.7%, 23.9%, and 12.4% of patients, respectively; with intermediate implantation (node 5), in 31.0%, 29.2%, and 39.8%; and with low implantation (node 4), in 3.5%, 16.8%, and 79.6%. In multivariable analysis, smaller sino-tubular junction diameter was independently associated with severe geometric coronary constraint.Geometric coronary constraints that may affect coronary access after redo TAVR with S3-in-Evolut configurations depend on the implantation depth of both the index Evolut and the simulated S3. However, the hemodynamic significance and clinical impact of these geometric findings require validation through flow studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.